Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Dark Forest Capital Management LP

Dark Forest Capital Management LP raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 110.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,566 shares of the medical equipment provider's stock after buying an additional 1,874 shares during the period. Dark Forest Capital Management LP's holdings in Intuitive Surgical were worth $1,861,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Alta Advisers Ltd grew its holdings in Intuitive Surgical by 18.1% during the 4th quarter. Alta Advisers Ltd now owns 1,181 shares of the medical equipment provider's stock worth $616,000 after acquiring an additional 181 shares in the last quarter. Fayez Sarofim & Co lifted its holdings in Intuitive Surgical by 4.4% during the 4th quarter. Fayez Sarofim & Co now owns 1,131,570 shares of the medical equipment provider's stock worth $597,323,000 after buying an additional 47,858 shares during the last quarter. J. Safra Sarasin Holding AG raised its position in shares of Intuitive Surgical by 66.8% during the 4th quarter. J. Safra Sarasin Holding AG now owns 10,409 shares of the medical equipment provider's stock worth $5,433,000 after acquiring an additional 4,168 shares in the last quarter. OneDigital Investment Advisors LLC increased its stake in Intuitive Surgical by 0.8% in the fourth quarter. OneDigital Investment Advisors LLC now owns 14,947 shares of the medical equipment provider's stock valued at $7,802,000 after purchasing an additional 118 shares during the last quarter. Finally, Van Lanschot Kempen Investment Management N.V. acquired a new stake in Intuitive Surgical during the 4th quarter worth $12,492,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research analyst reports. Truist Financial decreased their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a "neutral" rating and a $550.00 price objective for the company. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a report on Friday, January 24th. UBS Group lifted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Finally, Evercore ISI reduced their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $598.95.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 269 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president now owns 2,245 shares in the company, valued at $1,152,089.10. The trade was a 43.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 35,454 shares of company stock worth $18,564,027. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Down 1.2 %

Shares of NASDAQ ISRG traded down $5.93 during trading on Monday, reaching $508.66. 431,864 shares of the stock were exchanged, compared to its average volume of 1,612,472. The business's 50-day moving average price is $511.92 and its 200 day moving average price is $533.05. The company has a market capitalization of $181.17 billion, a price-to-earnings ratio of 79.41, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a twelve month low of $367.39 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the prior year, the business posted $1.50 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.